The Dopamine Hypothesis of Schizophrenia: An Historical and Philosophical Analysis
暂无分享,去创建一个
[1] Montagu Ka. Catechol Compounds in Rat Tissues and in Brains of Different Animals , 1957 .
[2] P. Seeman,et al. Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.
[3] R. V. Van Heertum,et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[4] L. Laudan. Progress and Its Problems , 1977 .
[5] J. Platt. Strong Inference: Certain systematic methods of scientific thinking may produce much more rapid progress than others. , 1964, Science.
[6] S. Stahl,et al. The dopamine hypothesis of schizophrenia: a review. , 1976, Schizophrenia bulletin.
[7] K. Fuxe,et al. EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS. , 1964, Acta physiologica Scandinavica. Supplementum.
[8] H. Chaiklin. Blaming the Brain: The Truth About Drugs and Mental Health. , 2000 .
[9] T. Broadbent,et al. Criticism and the Growth of Knowledge , 1972 .
[10] P. Willner. The dopamine hypothesis of schizophrenia: current status, future prospects. , 1997, International clinical psychopharmacology.
[11] K. Popper,et al. Conjectures and Refutations , 1963 .
[12] S. Snyder,et al. The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. , 1976, The American journal of psychiatry.
[13] J. Hietala,et al. Dopamine in schizophrenia. , 1996, Annals of medicine.
[14] C. Rădulescu,et al. Pink Spot as a Diagnostic Test in Schizophrenia , 1968, Nature.
[15] A. Serretti,et al. VNTR Polymorphism of Tyrosine Hydroxylase Gene and Schizophrenia in the Korean Population , 2003, Neuropsychobiology.
[16] B. Bunney,et al. Dopamine “Autoreceptors”: Pharmacological characterization by microiontophoretic single cell recording studies , 1977, Naunyn-Schmiedeberg's Archives of Pharmacology.
[17] G. Kirov,et al. No association between schizophrenia and polymorphisms in COMT in two large samples. , 2005, The American journal of psychiatry.
[18] E. Pinto,et al. [Psychostimulants]. , 1968, Revue medicale de Liege.
[19] J. Francis,et al. Historical Development of the Dopamine Hypothesis of Schizophrenia , 2002, Journal of the history of the neurosciences.
[20] Philip Kitcher,et al. Precis of The Advancement of Science@@@The Advancement of Science: Science without Legend, Objectivity without Illusions. , 1995 .
[21] O. Johansson,et al. Dopamine Nerve Terminals in the Rat Limbic Cortex: Aspects of the Dopamine Hypothesis of Schizophrenia , 1974, Science.
[22] T. C. Chamberlin. The Method of Multiple Working Hypotheses , 1931, The Journal of Geology.
[23] Michael A. Schwartz,et al. Philosophical Perspectives On Psychiatric Diagnostic Classification , 1994 .
[24] R. Tandon. Schizophrenia and other psychotic disorders in DSM-5. , 2013, Clinical schizophrenia & related psychoses.
[25] E. Jönsson,et al. The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: Evidence from fixed‐ and random‐effects meta‐analyses , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[26] P. Thagard,et al. How Scientists Explain Disease , 1999 .
[27] M. Hampson,et al. Dopa decarboxylase genotypes may influence age at onset of schizophrenia , 2001, Molecular Psychiatry.
[28] T. Sourkes. On the origin of homovanillic acid (HVA) in the cerebrospinal fluid , 2005, Journal of Neural Transmission.
[29] A. Carlsson,et al. A half-century of neurotransmitter research: impact on neurology and psychiatry , 2002, European Psychiatry.
[30] S. Snyder,et al. Prospects for research on schizophrenia. V. Pharmacological observations, Drug-induced psychoses. , 1972, Neurosciences Research Program bulletin.
[31] Peter Urbach,et al. Scientific Reasoning: The Bayesian Approach , 1989 .
[32] Yan Shen,et al. No association between polymorphisms in the DDC gene and paranoid schizophrenia in a northern Chinese population , 2004, Psychiatric genetics.
[33] J. Platt. Strong Inference , 2007 .
[34] I. Lakatos. Falsification and the Methodology of Scientific Research Programmes , 1976 .
[35] M. Kendall,et al. The Logic of Scientific Discovery. , 1959 .
[36] Karl R. Popper. The Logic of Scientific Discovery. , 1977 .
[37] A. Gjedde,et al. Quantification of Neuroreceptors in the Living Human Brain. I. Irreversible Binding of Ligands , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[38] S. Kety. H. CATECHOLAMINES IN NEUROPSYCHIATRIC STATES , 1966 .
[39] M. Vichnar,et al. [Borderline personality disorder]. , 1992, Ceskoslovenska pediatrie.
[40] N. Andreasen. Scale for the Assessment of Negative Symptoms (SANS) and Scale for the Assessment of Positive Symptoms (SAPS) 1982 , 2007 .
[41] O Hornykiewicz,et al. Dopamine in thelimbic regions of the human brain: normal and abnormal. , 1977, Advances in biochemical psychopharmacology.
[42] G L Ada,et al. The clonal-selection theory. , 1987, Scientific American.
[43] S. Faraone,et al. Meta-analysis shows schizophrenia is not associated with the 40-base-pair repeat polymorphism of the dopamine transporter gene , 2005, Schizophrenia Research.
[44] Dudley Shapere. Reason and the search for knowledge : investigations in the philosophy of science , 1984 .
[45] T. Terao,et al. Dopamine D1 receptor gene polymorphism and schizophrenia in Japan. , 1999, American journal of medical genetics.
[46] T. Hökfelt,et al. A fluorescence and electron microscopic study on central monoamine nerve cells , 1966, The Anatomical record.
[47] P. Kitcher. The Advancement of Science , 1993 .
[48] Kenneth S Kendler,et al. Toward a philosophical structure for psychiatry. , 2005, The American journal of psychiatry.
[49] O. Saitoh,et al. Differential Effects of Mental Stress on Plasma Homovanillic Acid in Schizophrenia and Normal Controls , 1999, Neuropsychopharmacology.
[50] H. Tuckwell,et al. A meta-analysis of homovanillic acid concentrations in schizophrenia. , 1993, The International journal of neuroscience.
[51] K. Davis,et al. The effects of diet and physical activity on plasma homovanillic acid in normal human subjects , 1983, Psychiatry Research.
[52] F. Oyebode,et al. Philosophical Issues in Psychiatry: Explanation, Phenomenology and Nosology , 2010, British Journal of Psychiatry.
[53] J. Rothwell. Principles of Neural Science , 1982 .
[54] C. Billington,et al. A review of GHRH stimulation test in psychiatry , 1994, Biological Psychiatry.
[55] S H Snyder,et al. Drugs, neurotransmitters, and schizophrenia. , 1974, Science.
[56] S. Cichon,et al. Dopamine D4 receptor gene (DRD4) variants and schizophrenia: meta-analyses , 2003, Schizophrenia Research.
[57] H. K. Lee,et al. The antagonism of amphetamine-induced symptomatology by a neuroleptic. , 1974, The American journal of psychiatry.
[58] I. Kopin. Parkinson's Disease: Past, Present, and Future , 1993, Neuropsychopharmacology.
[59] Paul William Preu,et al. Theory and Practice of Psychiatry , 1936, The Yale Journal of Biology and Medicine.
[60] E. Mignot,et al. Free and conjugated plasma homovanillic acid in schizophrenic patients , 1989, Biological Psychiatry.
[61] J. M. Schneck. A history of psychiatry , 1960 .
[62] T. M. Brown. The College of Physicians and the acceptance of iatromechanism in England, 1665-1695. , 1970, Bulletin of the history of medicine.
[63] T. Kuhn,et al. The Structure of Scientific Revolutions , 1963 .
[64] R. Sinke,et al. No association between 12 dopaminergic genes and schizophrenia in a large Dutch sample , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[65] M. Talkowski,et al. Dopamine genes and schizophrenia: case closed or evidence pending? , 2007, Schizophrenia bulletin.
[66] G. Thieme,et al. FLUORESCENCE OF CATECHOL AMINES AND RELATED COMPOUNDS CONDENSED WITH FORMALDEHYDE , 1962 .
[67] S. Matthysse,et al. Biochemical aspects of schizophrenia. , 1975, Annual review of medicine.
[68] J. Beckmann,et al. A highly significant association between a COMT haplotype and schizophrenia. , 2002, American journal of human genetics.
[69] S. Snyder,et al. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. , 1976, Science.
[70] G. Reynolds,et al. Plasma homovanillic acid in untreated schizophrenia--relationship with symptomatology and sex. , 2001, Journal of psychiatric research.
[71] J. Kebabian,et al. Multiple receptors for dopamine , 1979, Nature.
[72] Paul J. Harrison,et al. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.
[73] M. Munafo,et al. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case–control studies , 2005, Molecular Psychiatry.
[74] P. Sullivan,et al. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.
[75] R. Kahn,et al. Assessment of the central dopaminergic index of plasma HVA in schizophrenia. , 1995, Schizophrenia bulletin.
[76] L. W. Thompson. The dopamine hypothesis of schizophrenia. , 2009, Perspectives in psychiatric care.
[77] The molecular genetics of schizophrenia. , 1996 .
[78] Susan R. George,et al. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1 , 1991, Nature.
[79] W. Wilson,et al. A study of the potential confounding effects of diet, caffeine, nicotine and lorazepam on the stability of plasma and urinary homovanillic acid levels in patients with schizophrenia , 1996, Biological Psychiatry.
[80] K. Montagu. Catechol Compounds in Rat Tissues and in Brains of Different Animals , 1957, Nature.
[81] W. Livesley. The DSM-IV personality disorders. , 1995 .
[82] R. Gur,et al. Prognostic variables at intake and long-term level of function in schizophrenia. , 2006, The American journal of psychiatry.
[83] Astrophysical Observations: Lensing and Eclipsing Einstein's Theories , 2005, Science.
[84] M. Gazzaniga. The cognitive neurosciences, 3rd edition , 2004 .
[85] E. Walker,et al. Dopamine receptors in the brains of schizophrenia patients: a meta‐analysis of the findings , 2001, Behavioural pharmacology.
[86] Lin He,et al. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: A large-scale association study plus meta-analysis , 2005, Biological Psychiatry.
[87] I. Glick,et al. Schizophrenia and Other Psychotic Disorders , 2004 .
[88] Bruno Giros,et al. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics , 1990, Nature.
[89] J. Lacasse,et al. Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature , 2005, PLoS medicine.
[90] Edward Shorter,et al. A History of Psychiatry: From the Era of the Asylum to the Age of Prozac , 1996 .
[91] J. Lieberman,et al. Psychoneuroendocrinology of schizophrenia. , 1998, The Psychiatric clinics of North America.
[92] T. Kuhn. The structure of scientific revolutions, 3rd ed. , 1996 .
[93] Alan A. Wilson,et al. Dopamine D2 receptor density estimates in schizophrenia: A positron emission tomography study with11C-N-methylspiperone , 1993, Psychiatry Research.
[94] S. Schultz. Principles of Neural Science, 4th ed. , 2001 .
[95] Philip Seeman,et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine , 1991, Nature.
[96] S. Matthysse. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? , 1973, Federation proceedings.
[97] A. Carlsson. Does dopamine have a role in schizophrenia? , 1978, Biological psychiatry.
[98] J. Caplehorn,et al. Amphetamine psychosis. , 1990, British journal of addiction.
[99] A. Faurbye. The role of amines in the etiology of schizophrenia. , 1968, Comprehensive psychiatry.
[100] Sir Bernard Katz. Planning and following the unexpected in scientific research , 1994 .
[101] A. Carlsson,et al. EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.
[102] J. Dorling,et al. Bayesian personalism, the methodology of scientific research programmes, and Duhem's problem , 1979 .
[103] J. Peto,et al. Molecular pathology of schizophrenia: more than one disease process? , 1980 .
[104] U. Ungerstedt,et al. ASCENDING SYSTEMS OF CATECHOLAMINE NEURONS FROM THE LOWER BRAIN STEM. , 1964, Acta physiologica Scandinavica.
[105] T. C. Chamberlin. The Method of Multiple Working Hypotheses: With this method the dangers of parental affection for a favorite theory can be circumvented. , 1965, Science.
[106] F. Moeller,et al. Serum homovanillic acid levels in schizophrenic patients and normal control subjects , 1993, Psychiatry Research.
[107] S. Lal,et al. Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma? , 2001, Journal of psychiatry & neuroscience : JPN.
[108] G. Pearlson,et al. Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone. , 1993, Psychiatry research.
[109] L. Wolpert. Popper , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[110] P. Kitcher,et al. The advancement of science : science without legend, objectivity without illusions , 1995 .
[111] Anissa Abi-Dargham,et al. Do we still believe in the dopamine hypothesis? New data bring new evidence. , 2004, The international journal of neuropsychopharmacology.
[112] K. Davis,et al. Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.
[113] N. Foster,et al. Dopamine agonist treatment of schizophrenia with N-propylnorapomorphine. , 1986, Archives of general psychiatry.
[114] E. Bizzi,et al. The Cognitive Neurosciences , 1996 .
[115] R. Kaiser,et al. Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia , 2004, Psychiatric genetics.
[116] Alexander L. Miller,et al. Studies of Catecholamine Metabolism in Schizophrenia/Psychosis-I , 1993, Neuropsychopharmacology.
[117] D. Grandy,et al. Cloning and expression of a rat D2 dopamine receptor cDNA , 1988, Nature.
[118] D. Jeste,et al. Low dose bromocriptine: A study of acute effects in chronic medicated schizophrenics , 1984, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[119] K. Schaffner. Discovery and Explanation in Biology and Medicine , 1994 .
[120] S. Kety. Catecholamines in neuropsychiatric states. , 1966, Pharmacological reviews.
[121] Glenn Shafer,et al. Scientific Reasoning: The Bayesian Approach (3rd ed.), Colin Howson and Peter Urbach , 2007 .
[122] J. Lieberman,et al. Provocative tests with psychostimulant drugs in schizophrenia , 2004, Psychopharmacology.
[123] I. Lakatos,et al. Criticism and the Growth of Knowledge: Falsification and the Methodology of Scientific Research Programmes , 1970 .
[124] S. Kety. BIOCHEMICAL THEORIES OF SCHIZOPHRENIA. , 1965, International journal of psychiatry.
[125] S. Faraone,et al. DRD2 −141C insertion/deletion polymorphism is not associated with schizophrenia: Results of a meta‐analysis , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[126] G. Pearlson,et al. Quantification of Neuroreceptors in the Living Human Brain: IV. Effect of Aging and Elevations of D2-Like Receptors in Schizophrenia and Bipolar Illness , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[127] J. Csernansky,et al. Are there neurochemical indicators of risk for schizophrenia? , 1994, Schizophrenia bulletin.